**SCHEDULE 11**

 

**NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTEDPERSONS**

 

1) Name of company 

Cambridge Antibody Technology 

 

2) Name of director 

John Aston 

 

3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in thecase of an individual holder if it is a holding of that person’s spouse or children under the age of 18 or in respect of a non-beneficial interest 

Asin 2 above 

 

4) Name of the registered holder(s) and, if more than one holder,the number of shares held by each of them (if notified) 

Greenwood Nominees CREST Account 

 

5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connectedperson(s) 

As in 2 above 

 

6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary 

Sale and Purchase of shares following exercise of Options 

 

7) Number of shares/amount of stock acquired 

9,000 

 

8) Percentage of issued class 

0.0218% 

 

9) Number of shares/amount of stockdisposed 

4,912 

 

10) Percentage of issued class 

0.0119% 

 

11) Class of security 

Ordinary 10 pence shares

 

12) Price per share 

GBP6.13 

 

13) Date of transaction 

13 December 2004 

 

14) Date company informed 

13 December 2004 

 

15) Total holding following this notification 

43,088 

 

16) Total percentage holding of issued class following this notification 

0.104% 

 

If a director has been granted options by the company please complete the following boxes 

 

17) Date of grant 

 

18) Period during which ordate on which exercisable 

 

19) Total amount paid (if any) for grant of theoption 

 

20) Description of shares or debentures involved: class, number

 

21) Exercise price (if fixed at time of grant) or indication that price is tobe fixed at time of exercise 

 

22) Total number of shares or debentures overwhich options held following this notification 

 

23) Any additional information

The option which was exercised was due to irrevocably lapse on 19 December 2004 if it had not been exercised prior to that date. 

 

24) Name of contact and telephone number for queries 

Justin Hoskins, 01223 898589 

 

25) Name and signature of authorised company official responsible for making this notification 

Diane Mellett, CompanySecretary 

 

Date of Notification. 14 December 2004 

 

**SCHEDULE 11**

 

**NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS**

 

1) Name of company 

Cambridge Antibody Technology 

 

2) Name of director David Glover 

 

3) Pleasestate whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person’s spouse or childrenunder the age of 18 or in respect of a non-beneficial interest 

As in 2 above 

 

4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) 
GreenwoodNominees CREST Account in joint holding with spouse 
 

5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) 

As in 2 above 

 

6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary 

 

Purchase of shares following exercise of Options 

 

7) Number of shares/amount of stock acquired 

15,000 

 

8) Percentage of issued class 0.0363%

 

9) Number of shares/amount of stock disposed 
Nil
 

10) Percentage of issued class 

Nil 

 

11) Class of security 

Ordinary 10 pence shares 

 

12) Price per share 

GBP6.13 

 

13) Date of transaction 

13 December 2004 

 

14) Date company informed 

13 December 2004 

 

15) Total holding following this notification 

28,730 

 

16) Total percentage holding of issued class following thisnotification 

0.0697% 

 

If a director has been granted options by the company please complete the following boxes 

 

17) Date of grant 

 

18) Period during which or date on which exercisable 

 

19) Total amount paid (if any) for grant of the option 

 

20) Description of shares or debentures involved: class, number 

 

21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 

 

22) Total number of shares or debentures over which options held following this notification 

 

23) Any additional information 
Theoption which was exercised was due to irrevocably lapse on 19 December 2004 if it had not been exercised prior to that date. 
 

24) Name of contact and telephone number for queries 

Justin Hoskins, 01223 898589 

 

25) Name and signature of authorised company official responsible for making this notification 

Diane Mellett, CompanySecretary 

 

Date of Notification. 14 December 2004